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In the event of a radioactive dispersal device (RDD), the assessment of the 
internal contamination level of a large number of potential victims is necessary to 
determine if immediate medical follow-up is necessary.  Since the current capacity to 
screen a large population by traditional whole body counting or laboratory analysis of 
urine specimen is limited, any means to quickly screen the population and prioritize 
victims for further analysis would be a valuable tool for emergency responders.  
Previously, hand-held gamma radiation detectors have been investigated for rapid 
screening.  In this study, Thermo Scientific’s TPM-903B Portal Monitor was investigated 
to determine if it is a suitable first cut screening tool for internal contamination 
assessment of victims. The TPM-903B was chosen for this study because it is readily 
accessible, transportable, easy to assemble, and provides whole body count rates.  The 
portal monitor was modeled in Monte Carlo N-Particles Transport Code Version 5 
(MCNP) [26]. This computational model was validated against the portal monitor’s 
response to a series of benchmark measurements made with four point sources and 
performed in a polymethyl methacrylate (PMMA) slab box.  
Using the validated MCNP detector model, in conjunction with MCNP models of 
six MIRD male and female anthropomorphic phantoms, the response of the portal 
monitor was simulated for the inhalation and ingestion of airborne radionuclides from an 
RDD. The detectable radionuclides investigated were Co-60, Cs-137, I-131 and Ir-192. 
The following six phantoms were considered in conjunction with the aforementioned 
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radionuclides: Reference Male, Reference Female, Adipose Male, Adipose Female, Post-
Menopausal Adipose Female, and 10-Year-Old Child.  
Biokinetics via Dose and Risk Calculation Software (DCAL) were used to 
determine the distribution of the radionuclides in the phantoms over a period of 30 days 
[7].  DCAL was implemented for both the inhalation and ingestion pathways.  The 
MCNP simulation output was multiplied by the DCAL to determine the count rate per Bq 
for each radionuclide, phantom type and internal contamination pathway for a period of 
30 days after exposure.  ICRP 72 dose coefficients were employed to determine the count 
rate of the detector associated with the committed effective dose of 250 mSv [8, 17].   
These count rates, referred to as trigger levels, were listed in internal contamination 
procedure sheets, which can be used by emergency response personnel to triage victims. 
The process used to develop the procedure sheets is summarized in the following flow 
chart.  Victims with count rates approximately equal to or greater than the trigger levels 
will have a higher priority for further testing and possible treatment.  There are four 
procedure sheets in total, two for adults and two for children. For each victim type there 
is an inhalation procedure sheet and an ingestion procedure sheet in which trigger levels 











With the risk of terrorist attacks facing the United States, preparation to respond 
to terrorist attacks which utilize radiological and nuclear devices is imperative.  One such 
device is the radiological dispersal device, or RDD.  An RDD is any method of 
dispersing radioactive material; this can be done through active or passive means.  An 
active method would be through an explosive device, referred to as a dirty bomb; while 
examples of passive methods include an aerial release of a radionuclide or contamination 
of a water supply [19].  In addition to causing harm and destruction, an RDD is used to 
create panic [1].  
For individuals in the immediate vicinity of an RDD, external and internal 
contamination could potentially occur.  Since it is not possible to see, smell, feel or taste 
radiation, individuals in the vicinity of the RDD will need to be evaluated for radioactive 
contamination. The majority of external contamination can be removed by removing 
clothing and washing with soap and water [19].  Once the external contamination is 
removed, evaluation of internal contamination should take place. When an RDD occurs 
there are two possible pathways of internal contamination; the first and most probable 
pathway is inhalation and the second pathway is ingestion.   
In the event of an RDD, the triaging of a large population may be necessary. In 
the triage decision making process it is necessary to distinguish individuals who are 
internally contaminated from those who are clean or whose contamination level is below 
the screening threshold. The goal is to utilize first cut screening tools to identify 
individuals in the public who have received a committed effective dose of at least 250 
mSv for the purpose of further testing and possibly treatment.  NCRP 161 recommends 
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250 mSv as the threshold value for further testing and possible treatment; for this reason 
250 mSv was chosen as the committed effective dose value of interests in this study [17].  
Conventional methods to determine internal contamination include in-vitro 
monitoring through bioassay and in-vivo monitoring through non-portable whole body 
counters. Bioassays of urine, feces, nose blow, or blood can be performed to “determine 
quantity, location and retention of radionuclides in the body” [13]. However, all bioassay 
samples, other than the nasal swab for the nose blow bioassay, must be taken by 
organizations that specialize in handling blood and excreta samples [13].  In addition, 
with both in-vitro and in-vivo conventional screening methods, only a limited number of 
victims can be screened. Since a large population could potentially be affected by an 
RDD, quick preliminary methods are needed to prioritize individuals for further testing 
via conventional methods.   
Three types of radiation can be emitted by radionuclides: alpha, beta, and gamma.  
Quick preliminary methods for evaluating contamination of individuals are needed for 
each type of radiation. Using criteria such as radiological toxicity, quantity, half-life, and 
dispersibility, the DOE and NRC have identified particular radioisotopes as isotopes of 
greatest concern for use in an RDD [22].  For gamma emitting radionuclides of greatest 
concern, several detectors have previously been evaluated as first cut screening tools, 
including Canberra’s 802-2x2-inch Sodium-Iodide Detector and two Geiger-Mueller 
pancake probe detectors [6,16].  Building upon the previous detector evaluations, this 
work focused on determining the validity of using portal monitors as a first cut screening 
tool for possible internal contamination of gamma emitting radionuclides; specifically 
cobalt-60, cesium-137, iodine-131, and iridium-192. This work was performed with an 
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end goal of developing procedure sheets that can be used by emergency response 
personnel to prioritize people for further screening, laboratory analysis, and possible 
treatment.  
 Portal monitors have several features that make them useful when a large 
population is potentially affected by an RDD.  These features included their 
transportability, ease of assembly and operation, and their wide availability. Because of 
the long linear extent of the detector in the vertical direction, portal monitors act as whole 
body counters, this means that only one measurement needs to be taken.  The ability to 
collect a whole body count with a single measurement helps to increase the already 
relatively large throughput, which is very important for first cut screening tools.  This 
work was performed for the Centers for Disease Control and Prevention (CDC), 
headquartered in Atlanta, Georgia.  The state of Georgia has a acquired TPM-903B Portal 
Monitors by Thermo Scientific; two portal monitors for each of the 18 health districts and 
the same model portal monitor was purchased for a number of selected hospitals 
throughout the state. For this reason Thermo Scientific’s TPM-903B Portal Monitor was 
investigated in this research to determine if it is suitable to assay the level of internal 
contamination of victims.  This study does not imply an endorsement of this or any 
particular instrument model and a similar approach can be used to investigate other 









In order to determine the feasibility of portal monitors as first cut screening tools, 
a series of point source measurements (benchmark measurements) were taken with the 
TPM-903B Portal Monitor. These measurements were performed for several different 
point sources surrounded by various thicknesses of polymethyl methacrylate (PMMA). 
The TPM-903B Portal Monitor, point sources and PMMA geometries were modeled in 
Los Alamos’s Monte Carlo N-Particle Transport Code, Version 5 [26].  The MCNP 
detector model was validated by comparison against the portal monitor’s actual 
measurements. A scaling factor between the model and measured values was calculated 
by dividing the MCNP counts by the measured counts. Once the detector model was 
validated, MCNP models of MIRD phantoms and the portal monitor were combined with 
organ concentrations from Dose Calculation Software (DCAL) and ICRP 72 Dose 
Coefficients to determine the count rate corresponding to a committed effective dose of 
250 mSv. These count rates were then used to produce internal contamination procedure 
sheets for the use of portal monitors as first cut screening tools.   
 
 
2.1 TPM-903B Portal Monitor  
 
Thermo Scientific's TPM-903B Transportable Radiation Portal Monitor was 
investigated. This portal monitor consists of two BC408 plastic scintillators, with a total 
volume of 10.4 liters, surrounded on the three exterior sides by 1.6 mm of lead shielding 
and encased in PVC piping.  According to Thermo Scientific’s website the TPM 903B 
Portal Monitor detects gamma rays in the energy range of 60 keV to 2 MeV, weighs 
approximately 90 pounds, and operates in temperatures ranging from -4 to 122 degrees 
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Fahrenheit [23]. The TPM-903B Portal Monitor’s output is counts per second. A picture 










2.2 PMMA Benchmark Measurements  
Benchmark measurements were performed using a source box composed of 6 mm 
thick PMMA sheets.  A source holder consisting of a 6mm PMMA slab with a center cut 
out for the placement of a cylindrical source was inserted in the center of the PMMA box. 
Once the source was placed, varying thicknesses of PMMA were positioned on each side 
of the source holder between the source and the detector as shown below in Figure 2.2.1.  
Measurements were taken at 13 different PMMA thicknesses ranging from 6 mm to 115 
mm on each side of the source holder (including the source box thickness).  For each 
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measurement the count rate per second was averaged over a time interval of one minute 
for greater accuracy.  
 
 




In the benchmark measurements, PMMA was used because its attenuation of 
photons is similar to that of tissue and the multiple thicknesses of PMMA served to 
represent the attenuation effect of varying tissue thicknesses between the source and the 
detector.   The 13 different PMMA thickness measurements were repeated for each of the 
following radioisotopes: barium 133, cobalt 60, cesium 137, and sodium 22.  These four 
isotopes were chosen because they represent a wide range of photon energies, 30 keV to 
1.33 MeV, with sufficient photon emission intensities that lie within the TPM-903B’s 
detectable energy range of 60 keV to 2 MeV.  The properties of the isotopes used for 
point source measurements are shown below in Table 2.2.1.  Photon energies and 










Table 2.2.1. Isotopes Used in the Point Source Measurements and MCNP Models 
Isotope Photon Energy (MeV) Photon Emission Intensity 
Ba-133 
0.384, 0.356, 0.303, 0.276, 0.081, 
0.035, 0.031, 0.030 
0.089, 0.622, 0.184, 0.071, 0.338, 
0.122, 0.631, 0.341 
Co-60 1.332, 1.1730 0.999, 0.999 
Cs-137 0.662, 0.0322, 0.0318 0.898, 0.0392, 0.0213 




The benchmark measurements were taken with the source box located in five 
different positions.  For three of the positions, the source box was centered in the portal 
monitor, as illustrated in Figure 2.2.2.  In the first location, position 1, the source was at a 
height of 140 cm from the floor, while the height of position 2 was 133 cm and position 3 
was 116 cm.  For the other two benchmark measurement positions the source box was at 






























Cesium-137 was used in additional measurements to better identify the 
dependence of the count rate on source position.  These 27 additional measurements were 
taken with nine different positions at three different heights and minimum attenuation.  
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2.3 TPM-903B MCNP Model Validation 
The TPM-903B Portal Monitor and the benchmark measurements were modeled 
in MCNP. The benchmark measurements were modeled for the four isotopes for all 
thicknesses and source positions, resulting in 260 MCNP input files. A pulse height tally 
was executed over the BC408 material.  This pulse height tally gave the pulse height 
spectra for each isotope, PMMA thickness, and position as the normalized intensity in 
each energy bin per source particle. The count rates from the MCNP simulations were 
then calculated by summing the MCNP pulse height tally and multiplying it by the 
activity of the source and the photons per decay. The resulting simulated count rates were 
then compared to the actual count rate readings obtained during the benchmark 
measurements. The ratio of MCNP count rates to the measured count rate were computed 
and analyzed for all four isotopes and all 13 PMMA thicknesses.  The analysis of the 
ratios of the MCNP count rate to measured count rate included determining an energy 
cutoff to be used in modeling the TPM-903B. The energy cutoff was determined by 
summing the MCNP pulse height tally above various lower energy cutoffs and finding 
the ratio that was most consistent over the varying thicknesses for all isotopes and 
positions.  The energy cutoff was then applied to all simulation results by summing the 
MCNP pulse height tally for energies above the cutoff energy. 
The computational to measurement ratios were evaluated for the three different 
source heights inside the detector zone. The resulting ratios were then averaged for each 
isotope to obtain the scaling factor. Here the scaling factor refers to the mean value of the 
ratio for a given isotope over all thicknesses and averaged for different height locations. 
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This scaling factor can be used to adjust the simulated response for other more 
complicated geometries.  
  
 
2.4 MIRD Phantoms 
 
Using the validated MCNP5 model, in conjunction with MCNP models of the 
Medical Internal Radiation Dose (MIRD) male and female anthropomorphic phantoms, 
the response of the portal monitors were simulated for the inhalation and ingestion of 
airborne radionuclides considered radioisotopes of concern in the event of an RDD [22].  
The four radioisotopes considered in this research were cobalt-60, cesium-137, iodine -
131, and iridium-192. Along with these four isotopes, six MIRD based phantoms were 
considered: Reference Male, Reference Female, Adipose Male, Adipose Female, Post-
Menopausal Adipose Female, and 10-Year-Old Child.  Six anthropomorphic phantoms 
were used to provide the distribution of count rates corresponding to a committed 
effective dose of 250 mSv over a wide range of body shapes. 
The Reference Male and Reference Female phantoms were developed at Oak 
Ridge National Laboratory [5].  The three adipose phantoms were developed at Georgia 
Institute of Technology, by adding adipose tissue to the Reference Male and Reference 
Female and the model of the 10 year old androgynous child was constructed using Body 
Builder [21, 24].  The characteristics of the six anthropomorphic phantoms are 








Table 2.4.1. Characteristics of the Six Anthropomorphic Phantoms 
Phantom Height (cm) Mass (kg) Body Mass Index 
Reference Male 179 73.1 23 
Reference Female 168 56.5 20 
Adipose Male 179 93.7 30 
Adipose Female 168 73.9 26 
Post-Menopausal 
Adipose Female 
168 85.9 30 




2.5 Biokinetics and Trigger Levels  
Biokinetics via Dose and Risk Calculation Software (DCAL) were implemented 
to determine the distribution of the radionuclides for both inhalation and ingestion 
pathways. Developed at Oak Ridge National Laboratory, DCAL lists the amount of 
radioactivity distributed in each organ of interest in the body as a function of time [7].  
Dose coefficients obtained from Rad Toolbox were employed to determine the 
count rate of the detector associated with specific dose limits [8]. A committed effective 
dose of 250 mSv was chosen as the specific dose limit for this study because NCRP 161 
recommends that this effective dose value be used “as a screening level indicating the 
need for a more detailed investigation of tissue-specific absorbed doses” [17]. Therefore, 
the count rates corresponding to a committed effective dose of 250 mSv were determined 
for the various isotopes and phantoms.  These count rates, referred to as trigger levels, 
were then compiled into pocket-sized sheets to be used by first responders during the 




2.6 Assumptions   
In order to characterize the detectors for use in the event of an RDD, assumptions 
had to be made. The first assumption made was that all external contamination will be 
removed by showering and changing clothing before the victim enters the portal 
monitors.  In addition, the results of this research will only be used for first stage triage of 
internal contamination.  The procedure sheet count rates correspond to a committed 
effective dose  of 250 mSv and further evaluation is needed for people with count rates 
equal to or higher than the procedure sheet count rates.  It is also assumed that only one 
isotope is used in the RDD, and that the isotope has been identified prior to triage.  
Finally, it was assumed that the first cut screening of the victim will occur between six 
hours and 10 days after the time of contamination of the victim and that the initial time of 









3.1 TPM-903B Portal Monitor Model 
 
A detailed MCNP model of the TPM-903B was constructed for use in photon 
transport simulations.  Included in the model were the two BC408 plastic scintillators 
with dimensions of 183.0 x 7.5 x 3.8 cm, the lead shielding around the three sides, the 
PVC piping, and the aluminum feet. The dimensions of the TPM-903B were measured on 
the physical device.  A VisEd representation of the TPM-903B MCNP model is shown in 
Figure 3.1.1.  
 
                                              
 




The density and composition of the materials used in the MCNP model of the TPM-903B 








Table 3.1.1. Materials Used in Portal Monitor Computations 
Material Density  Composition 
BC408  1.032 g/cm
3
 91.5% carbon & 8.5% hydrogen 
PVC Piping  1.32 g/cm
3
 
56.7% chlorine, 38.5% carbon & 
4.8%  hydrogen 
Lead Shielding 11.3 g/cm
3
 100% lead 
Aluminum Feet 2.7 g/cm
3






75.5% nitrogen, 23.2% oxygen, 




3.2 PMMA Benchmark Model  
 
Once the detailed MCNP model of the portal monitor was complete, the source, 
PMMA box, and PMMA attenuation slabs were added to the MCNP model to simulate 
the benchmark measurements.  Models were created for all sources, source positions, and 
attenuation thicknesses. To simulate the detector response for each MCNP input file, a 
pulse height tally was performed over the BC408 material, giving the pulse height spectra 
for each isotope, PMMA thickness, and position as the normalized intensity in each 
energy bin per source particle.  
VisED representations of the MCNP models of the benchmark measurements are 
shown below in Figure 3.2.1, and a sample MCNP input file for the TPM-903B and 









Figure 3.2.1. MCNP Model of the Benchmark Measurements for Position 2 as Displayed 




The density and composition of the materials used in modeling the PMMA box and 
attenuating PMMA are listed below in Table 3.2.1, and the assay data of the four sources 
used during the benchmark measurements is summarized below in Table 3.2.2 [18].  
 
 
Table 3.2.1. Materials Used in Modeling PMMA Box 











75.5% nitrogen, 23.2% oxygen, 1.28% 










































Ba-133 12/13/05 5.2 10.7 7/29/10 3.9 
Co-60 12/09/05 5.1 5.27 7/29/10 2.8 
Cs-137/Ba-137m 12/09/05 4.9 30.0 7/29/10 4.4 





3.3 MIRD Phantom Model 
 
In order to simulate the response of the portal monitors to internal radiation in 
humans, six anthropomorphic human phantom MCNP models were used in conjunction 
with the MCNP TPM-903B Portal Monitor model.  In the MCNP simulation, the 
phantom was placed such that the anterior and posterior sides of the phantom faced the 
elements of the detector.  This orientation was chosen to achieve the highest count rate 
and is the suggested orientation of potentially contaminated individuals in the procedure 
sheets listed in Appendix D. An example MCNP input file of the Reference Male 
phantom inside the TPM-903B with an I-131 source is presented in Appendix B.  The 
VisED representations of the MCNP Reference Male, Adipose Male and Child phantoms 






















Figure 3.3.1. MCNP Models the Reference Male, Adipose Male and Child as Displayed 
VisEd  A) Frontal View of Reference Male Phantom   B) Side View of Adipose Male 











A B C 
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The distributions within the human body of the four radionuclides investigated in this 
work as potential RDD isotopes vary with radioisotope, contamination pathway, and 
time. The organs of interest in the MIRD phantoms for each radioisotope (Co-60, Cs-137, 
I-131 and Ir-192) were ascertained using biokinetic modeling.  DCAL was implemented 
for the biokinetic modeling to determine the concentration of each radionuclide over a 30 
day period after internal contamination for both inhalation and ingestion pathways. For 
each radionuclide-phantom-pathway combination, a unit source was placed in each organ 
of interest and a pulse height tally was performed to obtain the counts per unit source for 
each organ.  To identify the organ in which each source particle originated, an SCX 
special treatment for the pulse height tally was implemented [26].  The MCNP output 
was then multiplied by the number of particles per decay to give the count rate per Bq for 
each organ of interest.  These steps were repeated for all radionuclide-phantom-pathway 
combinations.   
 
 
3.4 Biokinetic Modeling and Trigger Levels 
 
The MCNP pulse height tally output was used in conjunction with Oak Ridge 
National Laboratory’s Dose and Risk Calculation Software (DCAL) and Radiological 
Toolbox to evaluate trigger levels corresponding to a committed effective dose of 250 
mSv for each radionuclide of interest and each phantom. The MCNP pulse height tally 
for each MIRD organ, or region of interest for a particular isotope, was summed for all 
energies above the energy cutoff.  The sum was then multiplied by the number of photons 
per decay converting the MCNP output of intensity (or fraction of count) to counts per 
second (CPS) per Bq, as shown in the equation below.  For each radionuclide, the number 




                                       
          
 
                    
       
 




The resulting CPS per Bq for each organ of interest in each phantom was multiplied 
by the corresponding biokinetics, determined by DCAL, for each radionuclide and region 
of interest.  The DCAL software was run twice for each of the four radioisotopes of 
concern; the mode of uptake was set to inhalation on the first run and ingestion on the 
second. The method of uptake for both scenarios was set to environmental and the 
particle size activity median aerodynamic diameter (AMAD) was set to 1µm for both 
scenarios in DCAL.  The CPS per Bq results were used along with the DCAL from the 
two different modes of uptake to calculate two sets of values, one for inhalation and one 
for  ingestion. The DCAL outputs for Cs-137 and I-131 are displayed in Figures 3.4.1-
3.4.4. The DCAL outputs for these two radionuclides illustrate the variations in source 
distribution in the body based on the radionuclide; Cs-137 distributes relatively evenly 




















































































































































































































  For both modes of uptake the blood DCAL was distributed to each organ based on 
the blood distributions listed in ICRP 89, and the body tissue received the remaining 
fraction of blood that was not distributed to the organs [11]. For the child MCNP 
simulation results the adult DCAL for each radioisotope was used, because it resulted in a 
lower count rate, thus providing more conservative selection criteria for the child. 
The count rate per Bq values were then divided by the scaling factor to adjust the 
simulated response to the response of the detector.  These values were then multiplied by 
the dose coefficients from Rad Toolbox for public ingestion and inhalation [8]. The dose 
coefficients listed in Rad Toolbox are based on the ICRP 72 values for Co-60, Cs-137, I-
131, and Ir-192 and are given in units of rem per Bq. ICRP recommended inhalation 
classes were utilized for the inhalation dose coefficients.  Slow (S), moderate (M) and 
fast (F) inhalation classes describe how quickly a radionuclide is absorbed in the lungs.  
The inhalation was set to fast for Cs-137 and I-131 and moderate for Co-60 according to 
the specifications of ICRP 72 [10]. In most of the inhalation absorption experiments 
conducted using different chemical forms of  Cs-137 and I-131, the lung absorption was 
found to be fast [9].  Thus, in the event that “specific information” about the chemical 
form is not given, a fast inhalation class is recommended for both Cs-137 and I-131 [9].  
All three inhalation classes have been observed in studies of various chemical forms of 
Co-60, for this reason ICRP recommends that the inhalation class of Co-60 be set to 
moderate when “specific information” about the chemical form is not known [9]. Since a 
recommended inhalation class for Ir-192 was not specified in ICRP 72, its inhalation 
class was assumed to be moderate. By assuming an inhalation class of moderate, the 
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likelihood of grossly overestimating or underestimating the dose coefficient is reduced 
[9].  The dose coefficients obtained from Rad Toolbox are listed below in Table 3.4.1.   
 
 
Table 3.4.1. Rad Toolbox Dose Coefficients for Adult and Child (rem per Bq) 
Phantom Co-60 Cs-137 I-131 Ir-192 
Adult Inhalation 1.00E-06 4.60E-07 7.40E-07 5.20E-07 
Child Inhalation 1.50E-06 3.70E-07 1.90E-06 7.60E-07 
Adult Ingestion 3.40E-07 1.30E-06 2.20E-06 1.40E-07 




Multiplying the count rate per Bq by the dose coefficients resulted in the count rate per 
rem.  The count rate per 25 rem was then calculated, giving a final result of counts per 








The first step in determining the feasibility of portal monitors as a first cut screening 
tool, was the acquisition of benchmark measurements used to validate an MCNP model 
of the TPM-903B.  The validation of the MCNP model led to scaling factors that relate 
the model to the measured values. Once the detector model was validated the MNCP 
model of the TPM-903B was combined with MIRD Phantoms to determine the count rate 
corresponding to a committed effective dose of 250 mSv. These count rates were then 
listed in internal contamination procedure sheets for the use of portal monitors as first cut 
screening tools.   
 
4.1 Lower Limit of Detection and Minimum Detectable Activity 
The lower limit of detection and the minimum detectable activity were calculated 
using the background recorded during the experimental measurements.  They were also 
calculated for double the background observed during the experimental measurements. 
These values we calculated following the procedure outlined by Knoll [14]. 
The lower limit of detection was calculated using the Currie Equation shown below 
[14]. 
                    
In this equation “ND as defined above can now be interpreted as the minimum number of 
counts needed from the source to ensure a false-negative rate no larger than 5% when the 
system is operated with a critical level of LC  that, in turn, ensures a false-positive rate of 
no greater than 5%” and     is the standard deviation of the background [14].  Once the 
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lower limit of detection was calculated the minimum detectable activity was calculated 
using the following equation: 
  
  
   
 
where f is the radiation yield per disintegration, T is counting time and   is the absolute 
detection efficiency [14].   
The equation shown below was used to calculate the absolute detection efficiency 
[14].  
   
                         
                                            
 
The absolute detection efficiency was determined using the recorded count for the 
thickest slab measurement for Co-60.  This thickness was chosen since it is similar to the 
thickness of a human body.  During benchmark measurements counts were taken for 
three different source heights in the center of the detector, these positions were referred to 
as 1, 2 and 3.  Because all three of these positions are located within the region which a 
human body would cover, the counts were average for the three positions and the average 
was used as the “number of pulses recorded”.  The minimum detectable activity was then 
calculated using a radiation yield per disintegration of two for Co-60 and a counting time 
of one second.  The values calculated as the lower limit of detection and minimum 











Table 4.1.1. TPM-903B Lower Limit of Detection and Minimum Detectable Activity of 
Co-60 
Background Level at Which Data Was Taken  
Background  4477 CPS 
Standard Deviation 67 CPS 
Lower Limit of Detection (above background) 314 CPS 
Lower Limit of Detection  4791 CPS 
Absolute Detection Efficiency 8.59E-03   
Minimum Detectable Activity of Co-60 1.83E+04 Bq 
Double Background Level 
Background  8954 CPS 
Standard Deviation 95 CPS 
Lower Limit of Detection (above background) 443 CPS 
Lower Limit of Detection  9397 CPS 
Absolute Detection Efficiency 8.59E-03   




4.2 PMMA Benchmark Measurement Results 
Benchmark measurements were taken with the TPM-903B portal monitor in order 
to validate the MCNP detector model.  The data taken during the benchmark 
measurements are shown in Figures 4.2.1-4.2.4.  For each of the radioisotopes the 
variation in count rate with change in attenuation thickness and source position can be 
seen.  When the sources were placed in the center between the two legs of the detector, 
the count rates were approximately two times larger than when the sources were placed 
slightly outside the detector.   The lower limit of detection is included in Figures 4.2.1-
4.2.4, to show that the counts per second recorded for the sources for all PMMA 
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The count rates corresponding to the additional 27 measurements taken using Cs-
137 are shown in Figure 4.2.5. The positions in which the source was next to a leg of the 
detector, positions 2 and 8, gave the highest counts with the next highest counts resulting 
from the central position, position 5 (see Figures 2.2.3 and 2.2.4).  In addition, all the 
positions located outside of the detector gave similar counts.  These trends were seen for 
all three source heights.  For simplicity and ease of use the central position, position 5, 
was used for phantom location in simulation and is recommended as victim location in 








4.3 Model Validation 
For Ba-133, Co-60, Cs-137, and Na-22, the count rates from the MCNP 

































A B C Lower Limit of Detection
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detector model.  The ratios of the simulated count rates to the measured readings were 
computed and analyzed for all PMMA thicknesses. In an ideal simulation the MCNP 
output would be exactly the same as the measured count rates resulting in a ratio of 
one regardless of the thicknesses of attenuation.  However, secondary effects not 
included in the modeling can lead to ratios that are not unity.  These secondary effects 
include the transport of scintillation light, as well as variations in material 
compositions and density and unknown variations in detection efficiency as a 
function of photon energy.  When the ratios are not unity, the scaling factor, which is 
the mean value of the ratio for a given isotope over all thicknesses, can be used to 
adjust the simulated response to the response that would be observed by the detector.  
In order to best simulate the response of the TPM-903B a low energy cutoff value 
was evaluated using the MCNP count rate to measured count rate ratio.  Gamma rays 
with energy below the low energy cutoff cannot be detected by the TPM-903B Portal 
Monitor. This low energy cut off value was determined by summing the MCNP 
pulse-height spectra above different energy thresholds until the simulated count rates 
formed the best match to the measured count rates at all PMMA thicknesses for all 
the radiation sources. According to Thermo Scientific the energy threshold of the 
detector is 60 keV [23]. This value was confirmed from the comparison of the MCNP 
simulated count rates to the measured count rates.  The MCNP output for Cs-137 at 
position 3 with 0.559 cm of PMMA attenuation can be seen in Figure 4.3.1. An 
example comparison of the experimental count rate values to the simulated count rate 






Figure 4.3.1. MCNP Output for Cs-137, Position 3 with 0.559 cm of PMMA Attenuation 
 
  
Figure 4.3.2. Comparison of the Experimental Count Rate Values and the Simulated 



























































After proper selection of the pulse-height threshold, the scaling factors for the three 
positions inside the detector were calculated.  The scaling factors for positions 1, 2, and 3 
(see Figure 2.2.2) are shown below in Figures 4.3.3-4.3.6.  Constant ratios of calculated 
to measured counts for all attenuator thicknesses were observed for positions 1 and 3.  
However, position 2 had a higher scaling factor value, which corresponded to the lower 
count rate observed for all isotopes at position 2 in the slab benchmark measurements. 
These trends were observed for all four radioisotopes used in the benchmark 
measurements. Since all three locations are of importance, as they represent individuals 
of differing heights, the scaling factors at the three heights were averaged to obtain the 
value applied in the anthropomorphic phantom modeling discussed in the next section.  
Benchmark measurements were not taken with I-131 and Ir-192; therefore their 
scaling factors were calculated by interpolating the scaling factors from the isotopes used 
in the benchmark measurements.  This interpolation was performed using the mean 
photon energies for the isotopes. The scaling factors were then used to convert the MCNP 
simulation of the TPM-903B and phantoms count rates to the detector count rates.  The 
scaling factors for all of the isotopes are listed below in Table 4.3.1. 
 
 
Table 4.3.1. Scaling Factors 






































































































































4.4 MIRD Phantom Results 
With the validation of the MCNP model complete, the TPM’s count rates 
corresponding to a committed effective dose of 250 mSv were determined.  Count rates 
were determined for both the inhalation and ingestion of Co-60, Cs-137, I-131 and Ir-
192. The isotopes were used in conjunction with six anthropomorphic stylized phantoms: 
Reference Male, Reference Female, Adipose Male, Adipose Female, Post-Menopausal 
Adipose Female, and 10-Year Old Child.  The comparison of the phantom counts per 
second corresponding to a committed effective dose of 250 mSv can be seen in Figures 
4.4.1-4.4.8.  This comparison is shown for each radionuclide and both internal 
contamination pathways for a time period of thirty days after contamination.   
 As seen in the graphs, the Adipose Male consistently gives the lowest or equal to 
the lowest count rate per 250 mSv for both inhalation and ingestion and all isotopes.  
Thus, the Adipose Male provides the most conservative selection criteria for adult 
screening and for this reason the Adipose Male count rates were selected as the adult 
trigger levels. 
From Figures 4.4.3 and 4.4.6 one can see that 20 days after the ingestion of I-131 the 
count rate is approximately the same as the lower limit of detection for the background 
level that was observed in the experimental measurements.  This means that other 
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4.5 Trigger Levels  
Procedure sheets, for emergency response personnel, were compiled using the 
count rate per 250 mSv for the anthropomorphic phantoms.  The count rates 
corresponding to the effective dose threshold value of 250 mSv are listed as trigger levels 
in the procedure sheets. The Adipose Male results were used for the adult trigger levels 
because they give the lowest count rates which result in more conservative selection 
criteria.  Also the adult DCAL was used in determining the count rate for the child. This 
was chosen because it resulted in a lower count rate for an effective dose 250 mSv than 
the use of child DCAL, leading to more conservative selection criteria. The trigger levels 
used in the procedure sheets are listed in Tables 4.5.1-4.5.4. The procedure sheets can be 
found in Appendix D.  Trigger levels that are approximately the lower limit of detection 
or below the lower limit of detection are shaded gray.  
 
 










0.25 1.47E+04 1.33E+05 1.91E+04 1.80E+04 
0.50 1.45E+04 1.41E+05 1.06E+04 1.76E+04 
1.00 1.27E+04 1.47E+05 3.93E+03 1.57E+04 
2.00 9.52E+03 1.45E+05 1.89E+03 1.21E+04 
3.00 7.85E+03 1.41E+05 1.69E+03 1.01E+04 
4.00 7.03E+03 1.39E+05 1.61E+03 9.27E+03 
5.00 6.59E+03 1.36E+05 1.52E+03 8.87E+03 
6.00 6.31E+03 1.35E+05 1.44E+03 8.67E+03 
7.00 6.10E+03 1.33E+05 1.36E+03 8.54E+03 
10.00 5.64E+03 1.30E+05 1.12E+03 8.27E+03 
20.00 4.81E+03 1.21E+05 5.28E+02 7.60E+03 















0.25 1.13E+04 1.73E+05 8.40E+03 1.67E+04 
0.50 1.11E+04 1.83E+05 4.73E+03 1.61E+04 
1.00 9.59E+03 1.90E+05 1.86E+03 1.42E+04 
2.00 7.04E+03 1.87E+05 9.59E+02 1.05E+04 
3.00 5.71E+03 1.83E+05 8.63E+02 8.56E+03 
4.00 5.08E+03 1.79E+05 8.12E+02 7.71E+03 
5.00 4.74E+03 1.77E+05 7.65E+02 7.32E+03 
6.00 4.54E+03 1.74E+05 7.19E+02 7.13E+03 
7.00 4.39E+03 1.72E+05 6.74E+02 7.01E+03 
10.00 4.06E+03 1.68E+05 5.49E+02 6.76E+03 
20.00 3.47E+03 1.57E+05 2.53E+02 6.15E+03 

















0.25 7.65E+04 5.52E+04 1.43E+04 7.24E+04 
0.50 7.81E+04 5.92E+04 7.57E+03 7.06E+04 
1.00 6.46E+04 6.17E+04 2.32E+03 5.70E+04 
2.00 4.13E+04 6.09E+04 7.59E+02 2.94E+04 
3.00 2.96E+04 5.95E+04 6.67E+02 1.50E+04 
4.00 2.41E+04 5.84E+04 6.54E+02 9.02E+03 
5.00 2.13E+04 5.75E+04 6.40E+02 6.63E+03 
6.00 1.96E+04 5.67E+04 6.22E+02 5.67E+03 
7.00 1.84E+04 5.61E+04 6.00E+02 5.24E+03 
10.00 1.57E+04 5.46E+04 5.22E+02 4.74E+03 
20.00 1.12E+04 5.10E+04 2.71E+02 3.92E+03 

















0.25 2.82E+04 9.04E+04 8.12E+03 2.77E+04 
0.50 2.85E+04 9.70E+04 4.37E+03 2.71E+04 
1.00 2.36E+04 1.01E+05 1.43E+03 3.10E+04 
2.00 1.51E+04 9.98E+04 5.48E+02 2.02E+04 
3.00 1.08E+04 9.75E+04 4.85E+02 1.08E+04 
4.00 8.83E+03 9.56E+04 4.68E+02 6.37E+03 
5.00 7.79E+03 9.41E+04 4.51E+02 4.57E+03 
6.00 7.16E+03 9.29E+04 4.33E+02 3.83E+03 
7.00 6.71E+03 9.19E+04 4.13E+02 3.51E+03 
10.00 5.73E+03 8.94E+04 3.51E+02 3.16E+03 
20.00 4.10E+03 8.36E+04 1.75E+02 2.61E+03 









The TPM-903B Portal Monitor is a viable first cut screening tool for use in 
assaying internal contamination following an RDD if the radiation emitted is Co-60, Cs-
137,  I-131 or Ir-192.   The TPM-903B’s response to internal contamination of I-131 was 
modeled at the request of the CDC.  The other three gamma emitting isotopes were 
investigated because they are included in the isotopes of greatest concern for use in an 
RDD according to a recent NRC/DOE report [22]. However, the fourth gamma emitting 
isotope listed in the aforementioned report, Am-241, is undetectable when using the 
TPM-903B, because Am-241’s gamma ray energies are below the 60 keV energy cutoff 
of the TPM-903B.  Therefore another method of assaying internal contamination must be 
used if Am-241 is utilized in an RDD.  
The TPM-903B output count rates allow for the identification of individuals in the 
public who have received greater than or equal to an approximate committed effective 
dose of 250 mSv through inhalation or ingestion within 30 days of exposure to Co-60, 
Cs-137 or Ir-192.  For I-131, the TPM-903B allows for detection within 20 days of 
exposure due to I-131’s effective half-life.  The Adipose Male anthropomorphic phantom 
consistently gave the most conservative count rates of all the adults. Thus, the trigger 
levels listed in the procedures sheets for adults are those corresponding to the Adipose 
Male anthropomorphic phantom to provide more conservative triaging criteria and for 
simplicity. In conclusion the TPM-903B portal monitor is a useful tool in first cut 
screening of a large population after a radiological dispersal device. 
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In addition to evaluating the feasibility of the TPM-903B Portal Monitors as a 
first cut screening tool, preliminary data were acquired for Canberra’s MiniSentry 
Transportable Gamma Portal Monitor.  Future work includes further evaluation of the 
MiniSentry to determine trigger levels corresponding to the committed effective dose  
limit of 250 mSv, for the purpose of MiniSentry procedure sheets.  Further evaluation of 
the MiniSentry is relevant because it is a commercially available portal monitor.  
 For this work it was assumed that only one radionuclide will be used in an RDD.  
This may or may not be the case; therefore the development of procedure sheets listing 
trigger levels for mixed radionuclides would be a germane extension of this work.  
 Future work also includes evaluating trigger levels using ICRP’s Reference Male 
phantom and University of Florida’s Reference Male voxel phantom in order to compare 
the various phantoms. The phantom model type resulting in the most conservative trigger 
levels would be the preferred model for future work in evaluating first cut screening tools 









This is the MCNP5 input file for the benchmark measurement at a thickness of 
109 mm on each side of the source holder with a Co-60 source for the TPM-903B at 
position 3. The other input files for TPM-903B for the benchmark measurements only 




TPM 903B with Co-60 3A12 
c +++++++++++++++++               
c Cell Cards                    
c +++++++++++++++++++ 
c   BC408 Volume     
1   1 -1.032       -1 : -2                     imp:p=1 
c +++++++++++++++++++ 
c   Lead Shielding   
2   2 -11.3      -3 1 : -4 2                 imp:p=1 
c +++++++++++++++++++ 
c   Air in PVC Pipe  
3   3 -1.24e-3   -5 1 3 : -6 2 4 : -9        imp:p=1 
c +++++++++++++++++++ 
c   PVC Piping       
4   4 -1.32       -7 5 9 : -8 6 9 : -10 9 6 5 imp:p=1 
c +++++++++++++++++++ 
c   Aluminum Feet 
5   5 -2.7       -11 : -12                   imp:p=1 
c +++++++++++++++++++++ 
c   PMMA 
6   6 -1.19        -13 14:-15                  imp:p=1 
c +++++++++++++++++++++ 
c   Air Surrroundings  
100 3 -1.24e-3     7 8 10 11 12 -100  13:-14 15      imp:p=1 
c +++++++++++++++++++ 
c   Outside World    
101 0             100                        imp:p=0 
 
c ++++++++++++++++             
c Surface Cards                   
c +++++++++++++++++++ 
c   BC408 Volume     
1   RPP  53.45  57.25  -3.75 3.75  0 183 
2   RPP -57.25 -53.45  -3.75 3.75  0 183 
c +++++++++++++++++ 
c   Lead Shield    
3   RPP  53.45  57.41 -3.91 3.91  0 183 
4   RPP -57.41 -53.45 -3.91 3.91  0 183 
c ++++++++++++++++++++++++++++++++ 
c   Air between detector and PVC  
5   RCC 55.35    0 -17  0 0 217  4.694 
6   RCC -55.35   0 -17  0 0 217  4.694 
c +++++++++++++++++++++++ 
c   PVC Piping on sides  
7   RCC 55.35    0 -17  0 0 217  5.25 




c   PVC Piping on top  
9   RCC -60.044  0  195    120.088 0 0 4.694 
10  RCC -60.6    0  195    121.2  0 0 5.25 
c ++++++++++++++++++++++ 
c Aluminum Feet 
11  RPP 45.35   65.35  -30 30   -17.61 -17.01 
12  RPP -65.35 -45.35  -30 30   -17.61 -17.01 
c ++++++++++++++++++++++++++++++++++++++++ 
c   Air sphere where problem takes place  
100 SPH 0 0 90 130 
c ++++++++++++++++++++ 
c   Box source holder 
13  BOX -15.25 -23.15 82.41  30.5 0 0  0 46.3 0  0 0 38.85 
14  BOX -14.377 -22.2877 83.283 28.754 0 0  0 44.554 0  0 0 37.977  
c +++++++++++++++++++++ 
c   Source Holder 
15  RPP -11.15365 11.15365 -14.5 14.5 83.283 113.283 
 
c ++++++++++++++                
c Data Cards                   
c ++++++++++++++ 
c Materials 
M1 1000   0.5246   6000  0.4754                      $ BC408 
M2 82000 -1                                          $ Lead 
M3 8016 -.232 7014 -.755 6012 -1.2e-4 18000 -1.28e-2 $ Air, NIST 
M4 17000 0.166 1000 0.5 6000 0.334                   $PVC 
M5 13000 -1                                          $ Aluminum 
M6 6000.04p .556 8000.04p 0.296 1000.04p 0.148       $ PMMA                               
c ++++++++++++++              
c Tally                  
c ++++++++++++++ 
F8:P 1 
E8 0 1e-8 0.005 2000i 1.5 
c ++++++++++++++              
c Co-60 Source                 
c ++++++++++++++ 
sdef par=2 erg=d1 pos=0 -1.23 98.283 rad=d2 ext=d3 axs=0 1 0 
si1 l 1.33 1.17 
sp1 1 0.99 
si2 0 0.357 
sp2 -21 
si3 0 2.46  
mode p 
NPS 1e8 










This is the MCNP5 input file for the TPM-903B and the Reference Male 
anthropomorphic phantom with a I-131 source. The other input files differ by phantom 
type and source isotopes. 
 
 
TPM 903B Reference Male With I-131 
c air sphere 
1     1 -.001293    -1 (607:-37:606) (-606:601:35) (600:-35) & 
                    (-615:37:-43:44:4:-616) (37:-608:609) & 
                    (37:-608:610) 507 508 510 511 512 
2     2 -0.2958     ((-2 -4 3):(-2 4)) 5                                  $ left lung 
3     3 -0.9869     -7 51 -6 (-8:32) 84 101 #2 #24 #28 #58 #59 
                    (113:115) (114:115) #62 #700                          $ torso insd ribs/lvrtop-shldr 
4     3 -0.9869     -7 8 -32 117 113 114 #15 #16 #17 #18 #19 #20 #700 
                    (-4:-9:116:118:-119) (-4:-9:116:120:-121)             $torso 
5     3 -0.9869     -7 8 -117 51 113 114 #9 #13 #14 #700                  $ torso 
6     3 -0.9869     -7 50 -51 56 84 96 105 106 113 114 #10 #11 #12 
                    #27 #32 #43 #44 #47 #700                              $ torso 
7     3 -0.9869     -7 97 -50 (83:-86:87:-88) 113 114 #30 #33 #38 #39 
                    #63 #64 #65 #700                                      $ torso abdoman 
8     3 -0.9869     -7 37 -97 95 113 114 #31 #33 #38 #65 #66 #700         $ torso abdoman 
9     4 -1.4862     8 -9 5 -10                                            $ rib 
10    4 -1.4862     8 -9 11 -12                                           $ rib 
11    4 -1.4862     8 -9 13 -14                                           $ rib 
12    4 -1.4862     8 -9 15 -16                                           $ rib 
13    4 -1.4862     8 -9 17 -18                                           $ rib 
14    4 -1.4862     8 -9 19 -20                                           $ rib 
15    4 -1.4862     8 -9 21 -22                                           $ rib 
16    4 -1.4862     8 -9 23 -24                                           $ rib 
17    4 -1.4862     8 -9 25 -26                                           $ rib 
18    4 -1.4862     8 -9 27 -28                                           $ rib 
19    4 -1.4862     8 -9 29 -30                                           $ rib 
20    4 -1.4862     8 -9 31 -32                                           $ rib 
21    3 -0.9869     ((35 -34):(-33 6 -35)) 102 (84:85) 
                    #37 #60 #61 #62 #700                                  $ head 
22    3 -0.9869     -37 38 -39 103 #700                                   $ left leg 
23    3 -0.9869     -37 38 -40 104 #22 #700                               $ right leg 
24    2 -0.2958     ((-41 -4 42):(-41 4)) 5                               $ right lung 
25    3 -0.9869     715 -37 43 -44 -4 716 39 40 72 73 #700 #600           $ genitalia 
26    3 -0.9869     -47                                                   $ brain 
27    3 -0.9869     50 -51 -48 -49 #10 #11 #12                            $ liver 
28    3 -0.9869     (-52 54):(-53 -54 55)                                 $ heart 
29    3 -0.9869     -56                                                   $ stomach 
30    3 -0.9869     138 -57 58 -59                                        $ Ascending Colon Wall  
31    3 -0.9869     (-63 141 65 -61):(-64 142 37 -65)                     $ Sigmoid Colon Wall 
32    3 -0.9869     -62 139 66 -67 59                                     $ Transverse Colon Wall 
33    3 -0.9869     -60 140 61 -59 -83                                    $ Descending Colon Wall 
35    3 -0.9869     -72                                                   $ testicle 
36    3 -0.9869     -73                                                   $ testicle 
37    3 -0.9869     -74 75 -76 6 -77                                      $ thyroid 
38    4 -1.4862     -82 83 37 -78 80 (79:-81)                             $ pelvis 
39    4 -1.4862     -84 78 -85 102                                        $ spine 
40    3 -0.9869     -83 86 -50 88 -87 #30 #32 #33 #63 #64 #65             $ small int. 
41    1 -0.001293   -107 606 -4                                           $ air 
42    1 -0.001293   -108 606 -4                                           $ air 
50 
 
43    3 -0.9869     -92 65                                                $ kidney 
44    3 -0.9869     -93 -94                                               $ kidney 
45    3 -0.9869     -95                                                   $ bladder 
46    3 -0.9869     -96                                                   $ spleen 
47    3 -0.9869     -98 99 (-65:100)                                      $ pancreas 
48    3 -0.9869     -101                                                  $ thymus 
49    4 -1.4862     47 -102 #60 #61                                       $ skull 
50    4 -1.4862     -103 38 -37                                           $ leg bone 
51    4 -1.4862     -104 38 -37                                           $ leg bone 
52    3 -0.9869     -105 92                                               $ adrenal 
53    3 -0.9869     -106 93                                               $ adrenal 
54    4 -1.4862     37 -115 -113                                          $ arm bone 
55    4 -1.4862     37 -115 -114                                          $ arm bone 
56    4 -1.4862     4 9 -32 -116 117 -118 119                             $ scapulae 
57    4 -1.4862     4 9 -32 -116 117 -120 121                             $ scapulae 
58    4 -1.4862     -4 -122 -123 124                                      $ clavicle 
59    4 -1.4862     -4 -122 -125 126                                      $ clavicle 
60    3 -0.9869     -33 128 129 -130 133 -134 -4 #700                     $ eye lense 
61    3 -0.9869     -33 128 -131 132 133 -134 -4 #700                     $ eye lense 
62    3 -0.9869     -77 -137 51                                           $ oesophagus 
63    3 -0.9869     -138 58 -59                                           $ Ascending Colon Interior  
64    3 -0.9869     -139 66 -67                                           $ Transvers Colon Interior 
65    3 -0.9869     -140 61 -59 -83                                       $ Decending Colon Interior 
66    3 -0.9869     (-141 65 -61) : (-142 37 -65)                         $ Sigmoid Colon Interior 
600   0             -600 35 34 : -601 33 -35 606 : &                $ Head & Neck 
                    -606 6 33 -607: -607 7 -6 37 507 508 510 511 512 : &   $ Shoulders & Torso 
  (((-46 616) (43 -44) (615 -37)):((615 -45)(610 609)(46 -4)(43 -44))): & $ Genitalia 
                    -610 40 -37 38 : -609 39 -37 38 : &                $ Legs 
                    -708 608 -609 : -708 608 -610 : &                     $ Feet 
                    -38 708 -610 40 : -38 708 -609 39                      
700   5 -1.04       700 35 102 -34 : 701 -33 -35 6 : &                    $ Head & Neck 
                    706 -6 701 -707 : 707 -7 -6 37 114 113 : &            $ Shoulders & Torso 
  (((46 -716)(43 -44)(609 610)(715 -37)):((-715 45)(610 609)(46 -4)(43 -44))): & $ Genitalia 
                    -40 710 -37 38 : -39 709 -37 38 : &                   $ Legs 
                    -38 708 -39 : -38 708 -40                             $ Feet 
c +++++++++++++++++++ 
c   BC408 Volume     
c +++++++++++++++++++ 
501   501 -1.032       -501 : -502                     
c +++++++++++++++++++ 
c   Lead Shielding   
c +++++++++++++++++++ 
502   502 -11.3      -503 501 : -504 502                  
c +++++++++++++++++++ 
c   Air in PVC Pipe  
c +++++++++++++++++++ 
503   503 -1.24e-3   -505 501 503 : -506 502 504 : -509        
c +++++++++++++++++++ 
c   PVC Piping       
c +++++++++++++++++++ 
504   504 -1.32       -507 505 509 : -508 506 509 : -510 509 506 505  
c +++++++++++++++++++ 
c   Aluminum Feet 
c +++++++++++++++++++ 
505   505 -2.7       -511 : -512                    
c +++++++++++++++++++++                       
51 
 
67    0             1 
 
1     SO  200 
2     SQ  23.04 10.24 1 0 0 0 -576 8.5 0 43.5 
3     SQ  23.04 10.24 1 0 0 0 -576 2.5 0 43.5 
4     PY  0.0 
5     PZ  43.5 
6     PZ  70 
706   PZ  69.8 
606   PZ  70.2 
7     SQ  1 4.0 0 0 0 0 -400.0 0 0 0 
707   SQ  0.002551 0.010412 0 0 0 0 -1 0 0 0  
607   SQ  0.002451 0.00961  0 0 0 0 -1 0 0 0  
8     SQ  1 3.15 0 0 0 0 -272.25 0 0 0 
9     SQ  1 3.01 0 0 0 0 -289.0 0 0 0 
10    PZ  44.9 
11    PZ  35.1 
12    PZ  36.5 
13    PZ  37.9 
14    PZ  39.3 
15    PZ  40.7 
16    PZ  42.1 
17    PZ  46.3 
18    PZ  47.7 
19    PZ  49.1 
20    PZ  50.5 
21    PZ  51.9 
22    PZ  53.3 
23    PZ  54.7 
24    PZ  56.1 
25    PZ  57.5 
26    PZ  58.9 
27    PZ  60.3 
28    PZ  61.7 
29    PZ  63.1 
30    PZ  64.5 
31    PZ  65.9 
32    PZ  67.3 
33    SQ  100 49 0 0 0 0 -4900 0 0 0 
701   SQ  0.021626 0.010412 0 0 0 0 -1 0 0 0 
601   SQ  0.01929 0.009612 0 0 0 0 -1 0 0 0 
34    SQ  7225 3540.25 4900 0 0 0 -354025 0 0 85.5 
700   SQ  0.021626 0.010412 0.014516 0 0 0 -1 0 0 85.5 
600   SQ  0.01929 0.009612 0.013212 0 0 0 -1 0 0 85.5 
35    PZ  85.5 
36    PZ  94 
37    PZ  0 
38    PZ  -80 
708   PZ  -80.215 
608   PZ  -80.415 
39  601  GQ  5.025 5 0 0 0 -1 -100 0 0 0 
709 603  GQ  5.05 5 0 0 0 -1 -100 0 0 0 
609 605  GQ  4.963 5 0 0 0 -1 -100 0 0 0 
40  600  GQ  5.025 5 0 0 0 1 100 0 0 0 
710 602  GQ  5.089 5 0 0 0 1 100 0 0 0 
610 604  GQ  4.963 5 0 0 0 1 100 0 0 0 
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41    SQ  23.04 10.24 1 0 0 0 -576 -8.5 0 43.5 
42    SQ  23.04 10.24 1 0 0 0 -576 -2.5 0 43.5 
43    P   10 0 1 -100 
44    P   10 0 -1 100 
45    PZ  -4.8 
715   PZ  -4.6 
615   PZ  -5.0 
46    P   0 10 1 -100 
716   P   0 10.2 1 -100 
616   P   0 9.8 1 -100 
47    SQ  2.25 1 1.91716 0 0 0 -81 0 0 86.5 
48    SQ  64 272.25 0 0 0 0 -17424 0 0 0 
49    P   9 7 -7.3256 -315 
50    PZ  27 
51    PZ  43 
52    GQ  45.2 59.9 47.9 17.5 -16.2 34.8 -1632.1 1204.8 -4898.2 124295.2 
53    SQ  1 1 1 0 0 0 -25 -1 -3 51 
54    P   .6943 -.3237 -.6428 -32.506 
55    P   5.2193 -2.4336 -0.916 -59.6345 
56    SQ  4 7.11 1 0 0 0 -64 8 -4 35 
57    SQ  1 1 0 0 0 0 -6.25 -8.5 -2.36 0 
58    PZ  14.45 
59    PZ  24 
60    GQ  4.54 3.53 .096 0 1.16 -0.166 -77.68 -10.08 -.223 323.52 
61    PZ  8.72 
62    SQ  0 2.25 6.25 0 0 0 -14.0625 0 -2.36 25.5 
63    TY  3 0 8.72 5.72 1.57 1.57 
64    TY  3 0 0 3 1.57 1.57 
65    PX  3 
66    PX  -10.5 
67    PX  10.5 
68    PX  -20 
69    PX  20 
70    PY  -30 
71    PY  -29 
72    SQ  11.9025 8.9401 3.8025 0 0 0 -20.115225 1.3 -8 -2.3 
73    SQ  11.9025 8.9401 3.8025 0 0 0 -20.115225 -1.3 -8 -2.3 
74    C/Z 0 -6 2.2 
75    C/Z 0 -6 1 
76    PY  -6 
77    PZ  75 
78    PZ  22 
79    PZ  14 
80    PY  -3 
81    PY  5 
82    C/Z 0 -3 12 
83    C/Z 0 -3.8 11.3 
84    SQ  6.25 4 0 0 0 0 -25 0 5.5 0 
85    PZ  78.5 
86    PZ  17 
87    PY  2.2 
88    PY  -4.86 
89    C/Z 0 -11. 0.6350 
90    C/Z 0 -11. 0.8636 
91    PZ  56.335 
92    SQ  1.49 13.44 1 0 0 0 -30.25 6 6 32.5 
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93    SQ  1.49 13.44 1 0 0 0 -30.25 -6 6 32.5 
94    PX  -3 
95    SQ  1 2.0557 2.0557 0 0 0 -24.5818 0 -4.5 8 
96    SQ  2.94 9 1 0 0 0 -36 11 3 37 
97    PZ  12 
98    SQ  1 225 25 0 0 0 -225 0 0 37 
99    PX  0 
100   PZ  37 
101   SQ  1.78 64 1 0 0 0 -16 -2 -6 60.5 
102   SQ  2.08 1 1.39 0 0 0 -96.04 0 0 85.5 
103   GQ  1 1 .0091 0 0 -.2005 -20 0 1.7857 87.75 
104   GQ  1 1 .0091 0 0 .2005 20 0 1.7857 87.75 
105   SQ  100 900 9 0 0 0 -225 4.5 6.5 38 
106   SQ  100 900 9 0 0 0 -225 -4.5 6.5 38 
107   SQ  1.39 .5 2 0 0 0 -70 -6.5 -3 50 
108   SQ  1.39 .5 2 0 0 0 -70 6.5 -3 50 
109   PX  17 
110   PX  6 
111   PX  -6 
112   PX  -17 
113   GQ  503.01 135.24 0 0 0 10.206 -19215 0 -202.0788 183257 
114   GQ  503.01 135.24 0 0 0 -10.206 19215 0 -202.0788 183257 
115   PZ  69 
116   SQ  1 3.7589 0 0 0 0 -361 0 0 0 
117   PZ  50.9 
118   P   0.25 -1 0 0 
119   P   0.8 -1 0 0 
120   P   -0.25 -1 0 0 
121   P   -0.8 -1 0 0 
122   TZ  0 11.1 68.25 20 0.7883 0.7883 
123   P   0.89415 1 0 11.1 
124   P   7.0342 1 0 11.1 
125   P   -0.89415 1 0 11.1 
126   P   -7.0342 1 0 11.1 
C      2 concentric elliptical cylinders and planes to define eye lenses 
127   SQ  100 64 0 0 0 0 -6400 0 0 0 
128   SQ  88.36 40.96 0 0 0 0 -3619.2256 0 0 0 
129   PX  2 
130   PX  4 
131   PX  -2 
132   PX  -4 
133   PZ  82.5 
134   PZ  84.5 
C      segmenting planes for RBM regions in leg and arm bones 
135   PZ  -22.8 
136   PZ  52.6 
C      Oesophagus 
137   SQ 0.16 1.0 0 0 0 0 -0.16 0.5 2.5 0                            $ Oesophagus Exterior 
C      Colon Wall 
138   SQ 1 1 0 0 0 0 -3.209 -8.5 -2.36 0                             $ Ascending Colon Interior 
139   SQ 0 0.9467 3.8927 0 0 0 -3.6854 0 -2.36 25.5 
140   GQ 1.796 2.496 0.0674 0 0.818 -0.066 -30.75 -7.12 -0.602 132.2 
141   TY 3 0 8.72 5.72 0.91 0.91                                     $ Upper Sigmoid Interior 
142   TY 3 0 0 3 0.91 0.91                                           $ Lower Sigmoid Interior 
c ++++++++++++++++ 
c   BC408 Volume     
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501 900 RPP  53.45  57.25  -3.75 3.75  0 183 
502 900 RPP -57.25 -53.45  -3.75 3.75  0 183 
c +++++++++++++++++ 
c   Lead Shield    
503 900 RPP  53.45  57.41 -3.91 3.91  0 183 
504 900 RPP -57.41 -53.45 -3.91 3.91  0 183 
c ++++++++++++++++++++++++++++++++ 
c   Air between detector and PVC  
505 900 RCC 55.35    0 -17  0 0 217  4.694 
506 900 RCC -55.35   0 -17  0 0 217  4.694 
c +++++++++++++++++++++++ 
c   PVC Piping on sides  
507 900 RCC 55.35    0 -17  0 0 217  5.25 
508 900 RCC -55.35   0 -17  0 0 217  5.25 
c +++++++++++++++++++++ 
c   PVC Piping on top  
509 900 RCC -60.044  0  195    120.088 0 0 4.694 
510 900 RCC -60.6    0  195    121.2  0 0 5.25 
c ++++++++++++++++++++++ 
c Aluminum Feet 
511 900 RPP 45.35   65.35  -30 30   -17.61 -17.01 
512 900 RPP -65.35 -45.35  -30 30   -17.61 -17.01 
 
C Data Cards 
tr600 -0.1 
tr601 0.1 




tr900 0 0 -64 0 1 0 1 0 0 0 0 1 
c VOL   0 9.89817E3 5.12539E4 7.01171E3 4.12839E3 3.75367E4 4.1204E4 & 
c      3.96266E4 3.42787E2 3.43057E2 3.41728E2 3.41505E2 3.3914E2 & 
c      3.38905E2 3.37704E2 3.38854E2 3.36585E2 3.35548E2 3.34261E2 & 
c      3.3525E2 1.09049E4 5.26806E4 5.19336E4 9.87788E3 8.35231E2 & 
c      8.24983E3 1.08532E4 3.48665E3 2.39203E3 5.46974E2 4.19631E2 & 
c      7.21861E2 5.2306E2 1.1077E2 1.11655E2 1.72154E2 3.63227E3 & 
c      5.17342E3 6.31233E3 0 0 8.49751E2 8.55366E2 1.48895E3 1.04544E3 & 
c      3.58882E2 1.45325E2 4.77509E3 8.25008E3 8.23095E3 5.80561E1 &  
c      5.70516E1 2.81453E3 2.80523E3 5.80932E2 5.89508E2 1.56404E2 & 
c      1.56141E2 1.09588E1 1.10836E1 2.31698E2 5.781E2 7.58053E2 & 
c      6.152E2 2.15848E2 1.23531E4 1.09131E4 1.6059E4 1.6059E4 & 
c      1.6059E4 1.6059E4 23.9241 9.2379 53.9171 10.2532 28.10780 & 
c      23.9241 9.2379 53.9171 10.2532 28.1078 23.9241 9.2379 53.9171 & 
c      10.2532 28.1078 23.9241 9.2379 53.9171 10.2532 28.1078 0 
IMP:P 1 71R 0 
C 
C Sources 
SDEF  PAR=2  ERG=D1  CEL=D2  RAD=fcel=D3  & 
      POS=fcel=D4  EXT=fcel=D5  AXS=fcel=D6  
SI1 L 0.029458 0.722893 0.0297792 0.080183 0.284298 0.636973 0.36448 
SP1 0.013568 0.01752 0.025171 0.025448 0.058825 0.07057 0.788898 
C Left Lung, Right Lung, Stomach, Small Int., Heart, Ascending Colon,  
C Sigmoid Colon, Transvers Colon, Descending Colon, Bladder,  
C Body Tissue (3, 4, 5, 6, 7, 8, 21, 22, 23, 25), Thyroid 
SI2 L 2 24 29 40 28 30 31 32 33 45 3 4 5 6 7 8 21 22 23 25 37 
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SP2 D 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
DS3 S 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 
DS4 L 8.5 0 43.4   -8.5 0 43.4   8 -4 35   0 -3.8 11.3   -1 -3 51   & 
      -8.5 -2.36 14.35   5 0 -0.1   -10.6 -2.36 25.5   8.72 0 8.52  & 
      0 -4.5 8   0 0 42.9   0 0 50.8   0 0 42.9   0 0 26.9          & 
      0 0 11.9   0 0 -0.1   0 0 69.9   10.5 0 -80.1   -10.5 0 -80.1 & 
      0 -8 -4.9   0 -6 69.9 
DS5 S 30 31 0 32 0 33 34 35 36 0 37 38 39 40 41 42 43 44 45 46 47 
DS6 L 0 0 1   0 0 1   0 0 0   0 0 1   0 0 0   0 0 1   0 0 1 & 
      1 0 0   0 0 1   0 0 0   0 0 1   0 0 1   0 0 1   0 0 1 & 
      0 0 1   0 0 1   0 0 1   0 0 1   0 0 1   0 0 1   0 0 1 
SI7  0 7.6 
SP7  -21 1 
SI8  0 7.6 
SP8  -21 1 
SI9  0 8.2 
SP9  -21 2 
SI10 0 11.4 
SP10 -21 1 
SI11 0 8.2 
SP11 -21 2 
SI12 0 2.6 
SP12 -21 1 
SI13 0 7.1 
SP13 -21 1 
SI14 0 3.85 
SP14 -21 1  
SI15 0 4 
SP15 -21 1  
SI16 0 5.2 
SP16 -21 2 
SI17 0 20.2 
SP17 -21 1 
SI18 0 20.3 
SP18 -21 1 
SI19 0 20.3 
SP19 -21 1 
SI20 0 20.3 
SP20 -21 1 
SI21 0 20.3 
SP21 -21 1 
SI22 0 20.3 
SP22 -21 1 
SI23 0 10.1 
SP23 -21 1 
SI24 0 11 
SP24 -21 1 
SI25 0 11 
SP25 -21 1 
SI26 0 8.1 
SP26 -21 1 
SI27 0 2.2 
SP27 -21 1 
SI30 0 24.6 
SP30 -21 0 
SI31 0 24.6 
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SP31 -21 0 
SI32 0 10.2  
SP32 -21 0 
SI33 0 9.75 
SP33 -21 0 
SI34 0 8.92 
SP34 -21 0 
SI35 0 21.2 
SP35 -21 0 
SI36 0 16 
SP36 -21 0 
SI37 0 27.2 
SP37 -21 0 
SI38 0 16.6 
SP38 -21 0 
SI39 0 8.1 
SP39 -21 0 
SI40 0 16.2 
SP40 -21 0 
SI41 0 15.2 
SP41 -21 0 
SI42 0 12.2 
SP42 -21 0 
SI43 0 24.2 
SP43 -21 0 
SI44 0 80.2 
SP44 -21 0 
SI45 0 80.2 
SP45 -21 0 
SI46 0 5 
SP46 -21 0 
SI47 0 5.2  
SP47 -21 0 
C 
c ++++++++++++++                 
c Tally    
F8:P 501 
E8 0 1e-8 0.005 2000i 1.5 
FT8 SCX 2 
c ++++++++++++++ 
C Material Cards 
C       THIS IS THE COMPOSITION FOR AIR 
M1    7014 -.7558 8016 -.2314 18000 -.0128 
C      THIS IS THE COMPOSITION FOR LUNG TISSUE 
M2    1001 -.1021 
      6012 -.1001 
      7014 -.0280 
      8016 -.7596 
     11023 -.0019 
     15031 -.0008 
     16032 -.0023 
     17000 -.0027 
     19000 -.0020 
     20000 -.0001 
     26000 -.0004 
C        THE COMPOSITION FOR TOTAL BODY MINUS SKELETON AND LUNGS 
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M3    1001 -.1047 
      6012 -.2302 
      7014 -.0234 
      8016 -.6321 
     11023 -.0013 
     12000 -.0002 
     15031 -.0024 
     16032 -.0022 
     17000 -.0014 
     19000 -.0021 
C      THE COMPOSITION FOR SKELETAL TISSUE 
M4    1001 -.0704 
      6012 -.2279 
      8016 -.4856 
      7014 -.0387 
     11023 -.0032 
     12000 -.0011 
     15031 -.0694 
     16032 -.0017 
     17000 -.0014 
     19000 -.0015 
     20000 -.0991 
c      Adult Tissues (Density = 1.04 g/cc) 
M5       1001  -0.10454 
         6012  -0.22663 
         7014  -0.02490 
         8016  -0.63525 
        11023  -0.00112 
        12000  -0.00013 
        14000  -0.00030 
        15031  -0.00134 
        16032  -0.00204 
        17000  -0.00133 
        19000  -0.00208 
        20000  -0.00024 
        26000  -0.00005 
        30000  -0.00003 
        37085  -0.000007217 
        37087  -0.000002783 
        40000  -0.00001 
c Materials 
M501 1000   0.5246   6000  0.4754                      $ BC408 
M502 82000 -1                                          $ Lead 
M503 8016 -.232 7014 -.755 6012 -1.2e-4 18000 -1.28e-2 $ Air, NIST 
M504 17000 0.166 1000 0.5 6000 0.334                   $PVC 
M505 13000 -1                                          $ Aluminum                              
lost 50 
c STOP NPS 1E8 F38 0.01 
NPS 4E9 
RAND GEN=2 SEED=1561615651 











Table C.1. CPS per 250 mSv for Reference Male Inhaled Co-60 
Total Body Count  








































































Lower Limit of Detection
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Table C.2. CPS per 250 mSv for Reference Male Inhaled Cs-137 
Total Body Count  







































































Total Body Count 
Lower Limit of Detection
61 
 
Table C.3. CPS per 250 mSv for Reference Male Inhaled I-131 
Total Body Count  
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Table C.4. CPS per 250 mSv for Reference Male Inhaled Ir-192 
Total Body Count  









































































Table C.5. CPS per 250 mSv for Reference Female Inhaled Co-60 
Total Body Count  









































































Lower Limit of Detection
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Table C.6. CPS per 250 mSv for Reference Female Inhaled Cs-137 
Total Body Count  
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Table C.7. CPS per 250 mSv for Reference Female Inhaled I-131 
Total Body Count  
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Table C.8. CPS per 250 mSv for Reference Female Inhaled Ir-192 
Total Body Count  
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Table C.9. CPS per 250 mSv for Adipose Male Inhaled Co-60 
Total Body Count  
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Table C.10. CPS per 250 mSv for Adipose Male Inhaled Cs-137 
Total Body Count  
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Table C.11. CPS per 250 mSv for Adipose Male Inhaled I-131 
Total Body Count  
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Table C.12. CPS per 250 mSv for Adipose Male Inhaled Ir-192 
Total Body Count  
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Table C.13. CPS per 250 mSv for Adipose Female Inhaled Co-60 
Total Body Count  
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Table C.14. CPS per 250 mSv for Adipose Female Inhaled Cs-137 
Total Body Count  
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Table C.15. CPS per 250 mSv for Adipose Female Inhaled I-131 
Total Body Count  
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Table C.16. CPS per 250 mSv for Adipose Female Inhaled Ir-192 
Total Body Count  
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Table C.17. CPS per 250 mSv for Post Menopausal Adipose Female Inhaled Co-60 
Total Body Count  
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Table C.18. CPS per 250 mSv for Post Menopausal Adipose Female Inhaled Cs-137 
Total Body Count  
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Table C.19. CPS per 250 mSv for Post Menopausal Adipose Female Inhaled I-131 
Total Body Count  
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Table C.20. CPS per 250 mSv for Post Menopausal Adipose Female Inhaled Ir-192 
Total Body Count  
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Table C.21. CPS per 250 mSv for 10-year-old Child Inhaled Co-60 
Total Body Count  
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Table C.22. CPS per 250 mSv for 10-year-old Child Inhaled Cs-137 
Total Body Count  
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Table C.23. CPS per 250 mSv for 10-year-old Child Inhaled I-131 
Total Body Count  
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Table C.24. CPS per 250 mSv for 10-year-old Child Inhaled Ir-192 
Total Body Count  
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Table C.25. CPS per 250 mSv for Reference Male Ingested Co-60 
Total Body Count  
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Table C.26. CPS per 250 mSv for Reference Male Ingested Cs-137 
Total Body Count  
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Lower Limit of Detection
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Table C.27. CPS per 250 mSv for Reference Male Ingested I-131 
Total Body Count  
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Table C.28. CPS per 250 mSv for Reference Male Ingested Ir-192 
Total Body Count  










































































Lower Limit of Detection
87 
 
Table C.29. CPS per 250 mSv for Reference Female Ingested Co-60 
Total Body Count  
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Table C.30. CPS per 250 mSv for Reference Female Ingested Cs-137 
Total Body Count  
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Table C.31. CPS per 250 mSv for Reference Female Ingested I-131 
Total Body Count  
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Table C.32. CPS per 250 mSv for Reference Female Ingested Ir-192 
Total Body Count  
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Table C.33. CPS per 250 mSv for Adipose Male Ingested Co-60 
Total Body Count  
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Table C.34. CPS per 250 mSv for Adipose Male Ingested Cs-137 
Total Body Count  
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Table C.35. CPS per 250 mSv for Adipose Male Ingested I-131 
Total Body Count  
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Table C.36. CPS per 250 mSv for Adipose Male Ingested Ir-192 
Total Body Count  
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Table C.37. CPS per 250 mSv for Adipose Female Ingested Co-60 
Total Body Count  
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Table C.38. CPS per 250 mSv for Adipose Female Ingested Cs-137 
Total Body Count  









































































Lower Limit of Detection
97 
 
Table C.39. CPS per 250 mSv for Adipose Female Ingested I-131 
Total Body Count  
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Table C.40. CPS per 250 mSv for Adipose Female Ingested Ir-192 
Total Body Count  
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Table C.41. CPS per 250 mSv for Post Menopausal Adipose Female Ingested Co-60 
Total Body Count  
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Table C.42. CPS per 250 mSv for Post Menopausal Adipose Female Ingested Cs-137 
Total Body Count  
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Table C.43. CPS per 250 mSv for Post Menopausal Adipose Female Ingested I-131 
Total Body Count  
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Table C.44. CPS per 250 mSv for Post Menopausal Adipose Female Ingested Ir-192 
Total Body Count  
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Table C.45. CPS per 250 mSv for 10-year-old Child Ingested Co-60 
Total Body Count  
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Table C.46. CPS per 250 mSv for 10-year-old Child Ingested Cs-137 
Total Body Count  
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Table C.47. CPS per 250 mSv for 10-year-old Child Ingested I-131 
Total Body Count  
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Table C.48. CPS per 250 mSv for 10-year-old Child Ingested Ir-192 
Total Body Count  
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 Attach aluminum feet to bottom of the PVC pipes. 
 String cables through top PVC pipe and place on top of the two sides.  
 Connect the cables to the bottom side of the display unit.    
 Connect the portal monitor to AC power or D-cell batteries and turn on. 
 The background will automatically be acquired once the portal monitor is 
turned on.  Record the background value. 
 Calibrate the portal monitor, following the instructions listed in the manual.  
 Set the background count parameter to 20 seconds and turn off the 
occupation alarm by setting the nsigma parameter to n=99.  
 Have the victims form a line at least 15 feet from the portal monitor. 
 Have each victim stand sideways inside the center of the portal monitor, 
facing the display unit. 
 Once victim enters the portal monitor manually set the mode to background 
mode by pushing the # button. After the victim has been in the portal 
monitor for approximately one minute write down the count rate.  
 After a count rate has been obtained, subtract the background count from 














0.25 1.47E+04 1.33E+05 1.91E+04 1.80E+04 
0.50 1.45E+04 1.41E+05 1.06E+04 1.76E+04 
1.00 1.27E+04 1.47E+05 3.93E+03 1.57E+04 
2.00 9.52E+03 1.45E+05 1.89E+03 1.21E+04 
3.00 7.85E+03 1.41E+05 1.69E+03 1.01E+04 
4.00 7.03E+03 1.39E+05 1.61E+03 9.27E+03 
5.00 6.59E+03 1.36E+05 1.52E+03 8.87E+03 
6.00 6.31E+03 1.35E+05 1.44E+03 8.67E+03 
7.00 6.10E+03 1.33E+05 1.36E+03 8.54E+03 
10.00 5.64E+03 1.30E+05 1.12E+03 8.27E+03 
20.00 4.81E+03 1.21E+05 5.28E+02 7.60E+03 










 Attach aluminum feet to bottom of the PVC pipes. 
 String cables through top PVC pipe and place on top of the two sides.  
 Connect the cables to the bottom side of the display unit.    
 Connect the portal monitor to AC power or D-cell batteries and turn on. 
 The background will automatically be acquired once the portal monitor is 
turned on.  Record the background value. 
 Calibrate the portal monitor, following the instructions listed in the manual.  
 Set the background count parameter to 20 seconds and turn off the 
occupation alarm by setting the nsigma parameter to n=99.  
 Have the victims form a line at least 15 feet from the portal monitor. 
 Have each victim stand sideways inside the center of the portal monitor, 
facing the display unit. 
 Once victim enters the portal monitor manually set the mode to background 
mode by pushing the # button. After the victim has been in the portal 
monitor for approximately one minute write down the count rate.  
 After a count rate has been obtained, subtract the background count from 














0.25 7.65E+04 5.52E+04 1.43E+04 7.24E+04 
0.50 7.81E+04 5.92E+04 7.57E+03 7.06E+04 
1.00 6.46E+04 6.17E+04 2.32E+03 5.70E+04 
2.00 4.13E+04 6.09E+04 7.59E+02 2.94E+04 
3.00 2.96E+04 5.95E+04 6.67E+02 1.50E+04 
4.00 2.41E+04 5.84E+04 6.54E+02 9.02E+03 
5.00 2.13E+04 5.75E+04 6.40E+02 6.63E+03 
6.00 1.96E+04 5.67E+04 6.22E+02 5.67E+03 
7.00 1.84E+04 5.61E+04 6.00E+02 5.24E+03 
10.00 1.57E+04 5.46E+04 5.22E+02 4.74E+03 
20.00 1.12E+04 5.10E+04 2.71E+02 3.92E+03 









 Attach aluminum feet to bottom of the PVC pipes. 
 String cables through top PVC pipe and place on top of the two sides.  
 Connect the cables to the bottom side of the display unit.    
 Connect the portal monitor to AC power or D-cell batteries and turn on. 
 The background will automatically be acquired once the portal monitor is 
turned on.  Record the background value. 
 Calibrate the portal monitor, following the instructions listed in the manual.  
 Set the background count parameter to 20 seconds and turn off the 
occupation alarm by setting the nsigma parameter to n=99.  
 Have the victims form a line at least 15 feet from the portal monitor. 
 Have each victim stand sideways inside the center of the portal monitor, 
facing the display unit. 
 Once victim enters the portal monitor manually set the mode to background 
mode by pushing the # button. After the victim has been in the portal 
monitor for approximately one minute write down the count rate.  
 After a count rate has been obtained, subtract the background count from 














0.25 1.13E+04 1.73E+05 8.40E+03 1.67E+04 
0.50 1.11E+04 1.83E+05 4.73E+03 1.61E+04 
1.00 9.59E+03 1.90E+05 1.86E+03 1.42E+04 
2.00 7.04E+03 1.87E+05 9.59E+02 1.05E+04 
3.00 5.71E+03 1.83E+05 8.63E+02 8.56E+03 
4.00 5.08E+03 1.79E+05 8.12E+02 7.71E+03 
5.00 4.74E+03 1.77E+05 7.65E+02 7.32E+03 
6.00 4.54E+03 1.74E+05 7.19E+02 7.13E+03 
7.00 4.39E+03 1.72E+05 6.74E+02 7.01E+03 
10.00 4.06E+03 1.68E+05 5.49E+02 6.76E+03 
20.00 3.47E+03 1.57E+05 2.53E+02 6.15E+03 









 Attach aluminum feet to bottom of the PVC pipes. 
 String cables through top PVC pipe and place on top of the two sides.  
 Connect the cables to the bottom side of the display unit.    
 Connect the portal monitor to AC power or D-cell batteries and turn on. 
 The background will automatically be acquired once the portal monitor is 
turned on.  Record the background value. 
 Calibrate the portal monitor, following the instructions listed in the manual.  
 Set the background count parameter to 20 seconds and turn off the 
occupation alarm by setting the nsigma parameter to n=99.  
 Have the victims form a line at least 15 feet from the portal monitor. 
 Have each victim stand sideways inside the center of the portal monitor, 
facing the display unit. 
 Once victim enters the portal monitor manually set the mode to background 
mode by pushing the # button. After the victim has been in the portal 
monitor for approximately one minute write down the count rate.  
 After a count rate has been obtained, subtract the background count from 














0.25 2.82E+04 9.04E+04 8.12E+03 2.77E+04 
0.50 2.85E+04 9.70E+04 4.37E+03 2.71E+04 
1.00 2.36E+04 1.01E+05 1.43E+03 3.10E+04 
2.00 1.51E+04 9.98E+04 5.48E+02 2.02E+04 
3.00 1.08E+04 9.75E+04 4.85E+02 1.08E+04 
4.00 8.83E+03 9.56E+04 4.68E+02 6.37E+03 
5.00 7.79E+03 9.41E+04 4.51E+02 4.57E+03 
6.00 7.16E+03 9.29E+04 4.33E+02 3.83E+03 
7.00 6.71E+03 9.19E+04 4.13E+02 3.51E+03 
10.00 5.73E+03 8.94E+04 3.51E+02 3.16E+03 
20.00 4.10E+03 8.36E+04 1.75E+02 2.61E+03 
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